Does the addition of vinorelbine to hormone therapy prolong survival of men with hormone-refractory prostate cancer?

被引：0
作者：
Pummer, K [1 ]
机构：
[1] Med Univ Graz, Dept Urol, A-8036 Graz, Austria
来源：
NATURE CLINICAL PRACTICE UROLOGY | 2005年 / 2卷 / 02期
关键词：
hormone therapy; prostate cancer; vinorelbine;
D O I：
10.1038/ncpuro0089
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：80 / 81
页数：2
相关论文
共 6 条
  • [1] A REEVALUATION OF NONHORMONAL CYTO-TOXIC CHEMOTHERAPY IN THE TREATMENT OF PROSTATIC-CARCINOMA
    EISENBERGER, MA
    SIMON, R
    ODWYER, PJ
    WITTES, RE
    FRIEDMAN, MA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) : 827 - 841
  • [2] EISENBERGER MA, 2004, J CLIN ONCOL S, V22
  • [3] Pummer K, 1997, EUR UROL, V32, P81
  • [4] Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points
    Tannock, IF
    Osoba, D
    Stockler, MR
    Ernst, DS
    Neville, AJ
    Moore, MJ
    Armitage, GR
    Wilson, JJ
    Venner, PM
    Coppin, CML
    Murphy, KC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) : 1756 - 1764
  • [5] YAGODA A, 1993, CANCER-AM CANCER SOC, V71, P1098, DOI 10.1002/1097-0142(19930201)71:3+<1098::AID-CNCR2820711432>3.0.CO
  • [6] 2-G
1